论文部分内容阅读
Objective: S.T.A.R.T. (Study of Travatan as Replacement Therapy) is an open label, multi-center, prospective, four week trial to evaluate the IOP lowering efficacy of Travatan (travoprost ophthalmic solution, 0.004%) in patients requiring prostaglandin analogue therapy. This analysis reports on patients that were on
Objective: START (Study of Travatan as Replacement Therapy) is an open label, multi-center, prospective, four week trial to evaluate the IOP lowering efficacy of Travatan (travoprost ophthalmic solution, 0.004%) in patients requiring prostaglandin analogue therapy. This analysis reports on patients that were on